← Back to all reports
Jorge Gonzalez
Disclaimer: This report is a statistical analysis of publicly available Medicare data.
The anomalies identified herein do not necessarily constitute findings or accusations of fraud.
Statistical deviation from peer benchmarks may have legitimate clinical or business explanations.
All patterns warrant further investigation and independent verification.
Composite Score
72.7
Risk Classification
priority
Anomaly Signals
5
Analysis Period
2021–2023
Executive Summary
Gonzalez is a Family Practice provider in FL whose Medicare billing patterns exhibit statistically significant anomalies across 5 distinct fraud dimensions, consistent with the submission of false claims totaling approximately $180,787. Most critically, this provider submitted Medicare claims during a period of active OIG exclusion — a per se violation of 42 USC 1320a-7 that renders every post-exclusion claim false as a matter of law. This exclusion is independently confirmed by 2 of 2 sources checked: OIG LEIE <a href="#source_leie" color="#1a6dcc">[OIG LEIE]</a>, CMS Part B billing records <a href="#source_partb" color="#1a6dcc">[CMS Part B Utilization]</a>. See Exhibit G2 for full cross-verification. Prescribing patterns show controlled substance or drug volumes that deviate significantly from specialty norms, potentially indicating medically unnecessary prescriptions or kickback-tainted prescribing. These patterns map to 2 strong fraud theories under the False Claims Act: Excluded Provider Billing, Controlled Substance Mill.
Key Findings
- Medicare billing activity detected during OIG exclusion period
- Provider practice address co-located with a pharmacy entity identified in NPPES
- Provider name or corporate structure matches pharmacy authorized official or parent organization
- Specialty Prescribing Mismatch
- Controlled substance prescribing rates significantly above specialty peers
BILLING ANOMALY ANALYSIS — Detailed statistical breakdown across 5 independent signals.
Peer comparison data showing deviation from specialty benchmarks. Financial impact assessment
with estimated overpayment calculations. Timeline and trend analysis showing multi-year patterns.
Prescribing analysis with controlled substance review. Industry payment correlation analysis.
Evidence strength assessment with corroboration matrix. Entity resolution findings.
Legal framework mapping to applicable False Claims Act provisions.
FINANCIAL IMPACT ASSESSMENT — Estimated single damages calculation. Treble damage projection
under 31 U.S.C. 3729. Per-claim civil penalty estimates ($13,946 to $27,894 per false claim).
Recovery breakdown by anomaly category.
PEER COMPARISON — Provider vs. specialty median, 90th percentile, and 95th percentile across
payment per service, services per beneficiary, and high-complexity coding ratio.
Data Sources: CMS Medicare Provider Utilization & Payment Data (Part B, 2021–2023),
CMS Part D Prescriber Data (2021–2023), CMS Open Payments (2021–2023),
HHS-OIG LEIE Exclusion List, NPPES NPI Registry. All data is publicly available.